Long acting beta-blockers in the twenty fourth hour

Area of Science:

• Cardiology
• Pharmacology
• Exercise Physiology

Background:

• Hypertension management often involves beta-blockers.
• Understanding the comparative efficacy of different beta-blocker formulations during exercise is crucial for patient care.
• Long-acting propranolol and sustained-action metoprolol are commonly prescribed beta-blockers.

Purpose of the Study:

• To compare the effects of long-acting propranolol (L.A.) and sustained-action metoprolol (S.A.) on exercise responses in hypertensive patients.
• To evaluate the 24-hour efficacy of these beta-blockers on blood pressure and heart rate.
• To assess the impact on oxygen uptake and blood glucose levels.

Main Methods:

• A randomized, placebo-controlled study involving 15 mild to moderate hypertensive patients.
• Exercise testing using a bicycle ergometer with continuous monitoring of heart rate, blood pressure, and ECG.
• Administration of 160 mg propranolol L.A., 200 mg metoprolol S.A., or placebo for seven days, with measurements taken 24 hours after the last dose.

Main Results:

• Propranolol L.A. demonstrated superior reduction in exercise-induced tachycardia compared to metoprolol S.A.
• Both drugs significantly reduced resting blood pressure after 24 hours, with propranolol L.A. being more effective in lowering exercise systolic blood pressure peaks.
• No significant effects were observed on oxygen uptake or blood glucose levels, and side effect incidence was low and similar to placebo.

Conclusions:

• Long-acting propranolol is more effective than sustained-action metoprolol in controlling exercise-induced heart rate elevation in hypertensive patients.
• Both beta-blockers offer significant 24-hour blood pressure control, with propranolol L.A. showing an advantage in managing exercise-induced systolic pressure surges.
• These findings support the use of propranolol L.A. for hypertensive individuals requiring exercise tolerance management.